<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2019-10-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination." This guidance, developed by the Oncology Center of Excellence at FDA, describes an optional streamlined submission process to determine whether use of an investigational in vitro diagnostic in an oncology clinical trial is considered significant risk, nonsig...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-22117</p>
    <p><strong>Publication Date:</strong> 2019-10-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/10/10/2019-22117/investigational-in-vitro-diagnostics-in-oncology-trials-streamlined-submission-process-for-study">https://www.federalregister.gov/documents/2019/10/10/2019-22117/investigational-in-vitro-diagnostics-in-oncology-trials-streamlined-submission-process-for-study</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-22117</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
